Green light to start marketing in Japan

Reig Jofre certified by the Japanese agency for the manufacture of a sterile injectable for hospital use.

  • The process is part of the agreement with Maruishi Pharma for the marketing of state-of-the-art injectables for hospital use in Japan, the second largest pharmaceutical market in the world.
  • Together with the European (EMA) and American (FDA) agencies, the Japanese agency is part of the three major medicine regulatory agencies in the world.
  • Reig Jofre estimates that the contract with Maruishi Pharma will contribute 10% of the annual volume of the company’s non-antibiotic sterile injectables.